1Fletcher CDM,Unni K,Mertens M.Word Health Organization classification of tumours.Pathology and genetics of tumors of softtissue and bone[M].Lyon:IARC Press,2002.14-46.
2Collins K,Jacks T,Pavletich NP.The cell cycle and cancer[J].Proc Natl Acad Sci U S A,1997,94(7):2776-2778.
3Baker SJ.A role for Cdk4 in angiogenesis[J].Cell Cycle,2010,9(13):2493.
4Fletcher CD,Akerman M,Dal Cin P,et al.Correlation betweenclinicopathological features and karyotype in lipomatous tumors.Areport of 178 cases from the Chromosomes and Morphology(CHAMP)Collaborative Study Group[J].Am J Pathol,1996,148(2):623-630.
5Pilotti S,Della Torre G,Lavarino C,et al.Molecularabnormalities in liposarcoma:role of MDM2 and CDK4-containing amplicons at 12q13-22[J].J Pathol,1998,185(2):188-190.
6Micci F,Teixeira MR,Bjerkehagen B,et al.Characterization ofsupernumerary rings and giant marker chromosomes in well-differentiated lipomatous tumors by a combination of G-banding,CGH,M-FISH,and chromosome-and locus-specific FISH[J].Cytogenet Genome Res,2002,97(1-2):13-19.
7Schneider-Stock R,Walter H,Radig K,et al.MDM2amplification and loss of heterozygosity at Rb and p53 genes:nosimultaneous alterations in the oncogenesis of liposarcomas[J].JCancer Res Clin Oncol,1998,124(10):532-540.
8Sirvent N,Coindre JM,Maire G,et al.Detection of MDM2-CDK4 amplification by fluorescence in situ hybridization in 200paraffin-embedded tumor samples:utility in diagnosing adipocyticlesions and comparison with immunohistochemistry and real-timePCR[J].Am J Surg Pathol,2007,31(10):1476-1489.
